InnovAge Holding Corp
NASDAQ:INNV
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.55
6.36
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
InnovAge Holding Corp
InnovAge Holding Corp
Net Issuance of Common Stock
InnovAge Holding Corp
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
InnovAge Holding Corp
NASDAQ:INNV
|
Net Issuance of Common Stock
-$179k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
DaVita Inc
NYSE:DVA
|
Net Issuance of Common Stock
-$1.4B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Net Issuance of Common Stock
-$211m
|
CAGR 3-Years
53%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-22%
|
|
|
CVS Health Corp
NYSE:CVS
|
Net Issuance of Common Stock
-$2.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Cigna Corp
NYSE:CI
|
Net Issuance of Common Stock
-$5.2B
|
CAGR 3-Years
12%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-15%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Net Issuance of Common Stock
-$113m
|
CAGR 3-Years
43%
|
CAGR 5-Years
31%
|
CAGR 10-Years
11%
|
|
InnovAge Holding Corp
Glance View
InnovAge Holding Corp. engages in the provision of a healthcare delivery platform. The company is headquartered in Denver, Colorado and currently employs 1,800 full-time employees. The company went IPO on 2021-03-04. The firm delivers its patient-centered care through the InnovAge Platform. InnovAge Platform is focused on frail, dual-eligible seniors, and it serve participants primarily through Program of All-inclusive Care for the Elderly (PACE). InnovAge Platform provides complete, coordinated healthcare to enable its frail, nursing home-eligible seniors to live independently in their homes and communities. The InnovAge Platform consists of Interdisciplinary Care Teams and community-based care delivery model. The firm's subsidiaries include TCO Intermediate Holdings, Inc., Total Community Options, Inc., InnovAge Investment Holdings, LLC, TCO Eastern Holdings, LLC, InnovAge Pennsylvania LIFE, LLC, InnovAge Virginia PACE Roanoke Valley, LLC, InnovAge Virginia PACE II, LLC, InnovAge Virginia PACE Charlottesville, LLC, Total Longterm Care Solutions, LLC, Total Longterm Care, Inc. and InnovAge Greater Colorado PACE-Loveland, LLC.
See Also
What is InnovAge Holding Corp's Net Issuance of Common Stock?
Net Issuance of Common Stock
-179k
USD
Based on the financial report for Jun 30, 2024, InnovAge Holding Corp's Net Issuance of Common Stock amounts to -179k USD.
You don't have any saved screeners yet
